Cargando…
Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses
Background: The present study aims to evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) for discriminating between benign and malignant solid renal masses. Methods: 18 patients with histopathologically confirmed benign solid renal masses (11 oncocytomas, seven angiomyolipoma...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699268/ https://www.ncbi.nlm.nih.gov/pubmed/33227984 http://dx.doi.org/10.3390/medicina56110624 |
_version_ | 1783616010689970176 |
---|---|
author | Geyer, Thomas Schwarze, Vincent Marschner, Constantin Schnitzer, Moritz L. Froelich, Matthias F. Rübenthaler, Johannes Clevert, Dirk-André |
author_facet | Geyer, Thomas Schwarze, Vincent Marschner, Constantin Schnitzer, Moritz L. Froelich, Matthias F. Rübenthaler, Johannes Clevert, Dirk-André |
author_sort | Geyer, Thomas |
collection | PubMed |
description | Background: The present study aims to evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) for discriminating between benign and malignant solid renal masses. Methods: 18 patients with histopathologically confirmed benign solid renal masses (11 oncocytomas, seven angiomyolipomas) as well as 96 patients with confirmed renal cell carcinoma (RCC) who underwent CEUS followed by radical or partial nephrectomy were included in this single-center study. CEUS examinations were performed by an experienced radiologist (EFSUMB Level 3) and included the application of a second-generation contrast agent. Results: Renal angiomyolipomas, oncocytomas, and renal cell carcinomas showed varying sonomorphological characteristics in CEUS. Angiomyolipomas showed heterogeneous echogenicity (57% hypo-, 43% hyperechoic), while all lesions showed rapid contrast-enhancement with two lesions also showing venous wash-out (29%). Notably, 9/11 oncocytomas could be detected in conventional ultrasound (64% hypo-, 9% hyper-, 9% isoechoic) and 2/11 only demarcated upon intravenous application of contrast agent (18%). All oncocytomas showed hyperenhancement in CEUS, venous wash-out was registered in 7/11 lesions (64%). Conclusions: In line with the current state of knowledge, no specific sonomorphological characteristics allowing for accurate distinction between benign and malignant solid renal masses in CEUS could be detected in our study. |
format | Online Article Text |
id | pubmed-7699268 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76992682020-11-29 Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses Geyer, Thomas Schwarze, Vincent Marschner, Constantin Schnitzer, Moritz L. Froelich, Matthias F. Rübenthaler, Johannes Clevert, Dirk-André Medicina (Kaunas) Article Background: The present study aims to evaluate the diagnostic performance of contrast-enhanced ultrasound (CEUS) for discriminating between benign and malignant solid renal masses. Methods: 18 patients with histopathologically confirmed benign solid renal masses (11 oncocytomas, seven angiomyolipomas) as well as 96 patients with confirmed renal cell carcinoma (RCC) who underwent CEUS followed by radical or partial nephrectomy were included in this single-center study. CEUS examinations were performed by an experienced radiologist (EFSUMB Level 3) and included the application of a second-generation contrast agent. Results: Renal angiomyolipomas, oncocytomas, and renal cell carcinomas showed varying sonomorphological characteristics in CEUS. Angiomyolipomas showed heterogeneous echogenicity (57% hypo-, 43% hyperechoic), while all lesions showed rapid contrast-enhancement with two lesions also showing venous wash-out (29%). Notably, 9/11 oncocytomas could be detected in conventional ultrasound (64% hypo-, 9% hyper-, 9% isoechoic) and 2/11 only demarcated upon intravenous application of contrast agent (18%). All oncocytomas showed hyperenhancement in CEUS, venous wash-out was registered in 7/11 lesions (64%). Conclusions: In line with the current state of knowledge, no specific sonomorphological characteristics allowing for accurate distinction between benign and malignant solid renal masses in CEUS could be detected in our study. MDPI 2020-11-19 /pmc/articles/PMC7699268/ /pubmed/33227984 http://dx.doi.org/10.3390/medicina56110624 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Geyer, Thomas Schwarze, Vincent Marschner, Constantin Schnitzer, Moritz L. Froelich, Matthias F. Rübenthaler, Johannes Clevert, Dirk-André Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses |
title | Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses |
title_full | Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses |
title_fullStr | Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses |
title_full_unstemmed | Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses |
title_short | Diagnostic Performance of Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Solid Renal Masses |
title_sort | diagnostic performance of contrast-enhanced ultrasound (ceus) in the evaluation of solid renal masses |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699268/ https://www.ncbi.nlm.nih.gov/pubmed/33227984 http://dx.doi.org/10.3390/medicina56110624 |
work_keys_str_mv | AT geyerthomas diagnosticperformanceofcontrastenhancedultrasoundceusintheevaluationofsolidrenalmasses AT schwarzevincent diagnosticperformanceofcontrastenhancedultrasoundceusintheevaluationofsolidrenalmasses AT marschnerconstantin diagnosticperformanceofcontrastenhancedultrasoundceusintheevaluationofsolidrenalmasses AT schnitzermoritzl diagnosticperformanceofcontrastenhancedultrasoundceusintheevaluationofsolidrenalmasses AT froelichmatthiasf diagnosticperformanceofcontrastenhancedultrasoundceusintheevaluationofsolidrenalmasses AT rubenthalerjohannes diagnosticperformanceofcontrastenhancedultrasoundceusintheevaluationofsolidrenalmasses AT clevertdirkandre diagnosticperformanceofcontrastenhancedultrasoundceusintheevaluationofsolidrenalmasses |